During the past decade, Manna Research conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 22 clinical trials were completed, i.e. on average, 56.4% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 9 clinical trials were completed. i.e. 47.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Manna Research" #1 sponsor was "Pfizer" with 12 trials, followed by "Amgen" with 5 trials sponsored, "Allergy Therapeutics" with 2 trials sponsored, "DexCom, Inc." with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Manna Research" #1 collaborator was "Assurex Health Ltd." with 1 trials as a collaborator, "Biotropics Malaysia Berhad" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Centre for Addiction and Mental Health" with 1 trials as a collaborator and "Genome Canada" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Manna Research" are "Hypoglycemia" (4 trials), "Diabetes Mellitus, Type 2" (3 trials), "Psoriatic Arthritis" (3 trials), "Type 1 Diabetes" (3 trials) and "Dermatitis, Atopic" (2 trials). Many other conditions were trialed in "Manna Research" in a lesser frequency.

Most popular intervention types in "Manna Research" are "Drug" (40 trials), "Biological" (11 trials), "Other" (7 trials), "Device" (4 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "GlucaGen" (2 trials), "ATB-346 low dose" (1 trials), "ATB-346 mid-dose" (1 trials) and "ATB-346 standard dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Manna Research" are 56 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Manna Research". 1 are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Manna Research, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Manna Research, 4 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".